James Paul Rickey, Senior VP and CFO at ALPINE IMMUNE SCIENCES, INC. (ALPN), bought 10,000 shares at $4.95 ($50K) on 2019-05-30, disclosed to the SEC on 2019-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ALPN | SELL | 2023-12-21 | $584K | — | Filing → |
| ALPN | SELL | 2023-12-18 | $2.0M | — | Filing → |
| ALPN | SELL | 2023-12-06 | $2.3M | — | Filing → |